| ALNYLAM PHARMACE.DL-,0001 |
| USA |
| Gesundheit |
| US02043Q1076 / A0CBCK |
| DUL (Frankfurt) / ALNY (NASDAQ) |
| FRA:DUL, ETR:DUL, DUL:GR, NASDAQ:ALNY |
| - |
| https://www.alnylam.com/ |
|
Alnylam Pharmaceuticals Inc. is a pioneering biote..
>Volltext.. |
| 35528.05 Mio. EUR |
| 35569.58 Mio. EUR |
| 2697.66 Mio. EUR |
| 269.78 Mio. EUR |
| 36.61 Mio. EUR |
| 0.26 EUR |
| 2330.62 Mio. EUR |
| 1252.37 Mio. EUR |
| 223.42 Mio. EUR |
| 1.75 |
| 45.4% |
| - |
| - |
| - |
| - |
| ALNYLAM |
| 12.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|